A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Glioblastoma|Non-small Cell Lung Cancer|Breast Cancer
Interventions: DRUG: TAS2940|DRUG: TAS2940
Sponsor: Taiho Oncology, Inc.